Voyager Therapeutics, Inc. (VYGR)

Voyager Therapeutics, Inc. (VYGR) is a healthcare company (biotechnology) based in the United States. The share price is $1.52, down 6.75% on the day, which values the company at $94.59M. Price as of 18 Nov 2026, 10:38 UTC, from Yahoo Finance.

Key facts

Share price
$1.52−6.75% today
Market value
$94.59M
Funk Score
27/100
Against its own history
Well below its usual priceusual price $4.30
200-week average
$5.9374% below
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Voyager Therapeutics, Inc. in more detail

VYGR trades at -1.2× next year's expected earnings, 3.8× sales. Measured against its own history, the price is 65% below what its usual multiples would imply ($4.30) — well below its usual price. It sits 74% below its 200-week average of $5.93.

Over the last five fiscal years Voyager Therapeutics, Inc. has compounded revenue -25.1% a year. Its Funk Score is 27 out of 100 (financial strength 3.8, profitability 0.4, growth 1.7, value 5.0, each out of 10).

In its favour: More cash than debt. Worth checking: Altman Z in the distress zone; Weak Piotroski score.

Voyager Therapeutics, Inc. (VYGR): questions and answers

What is Voyager Therapeutics, Inc.'s market cap?

Voyager Therapeutics, Inc. is valued at $94.59M at a share price of $1.52.

Is VYGR overvalued or undervalued?

Against its own history, VYGR is well below its usual price: the price is 65% below the $4.30 implied by the median multiples it has traded at (price / sales, price / book). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

Is VYGR above its 200-week moving average?

No. VYGR is 74.4% below its 200-week average of $5.93. Long-term investors watch that line because strong companies rarely trade below it for long.

How fast is Voyager Therapeutics, Inc. growing?

Over the last five fiscal years Voyager Therapeutics, Inc.'s revenue grew -25.1% a year; over ten years revenue grew 8.8% a year.

Does VYGR pay a dividend?

Voyager Therapeutics, Inc. does not currently pay a regular dividend.

Cite this page

Funkfolio, “Voyager Therapeutics, Inc. (VYGR) stock: price, valuation and fundamentals”, data as of 18 November 2026. https://funkfolio.com/stock/VYGR

Underlying data: Yahoo Finance; company filings with the SEC.